CDB-4124
| CDB-4124 | |
|---|---|
| |
| IUPAC name | 17α-acetoxy-21-methoxy-11β-[4-N,N-dimethylaminophenyl]-19-norpregna-4,9-diene-3,20-dione) |
| Identifiers | |
| CAS number | |
| MeSH | |
| Properties | |
| Molecular formula | C31H39NO5 |
| Molar mass | 505.65 |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references | |
|
WikiDoc Resources for CDB-4124 | |
|
Articles | |
|---|---|
|
Most recent articles on CDB-4124 | |
|
Media | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on CDB-4124 at Clinical Trials.gov Clinical Trials on CDB-4124 at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on CDB-4124
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Directions to Hospitals Treating CDB-4124 Risk calculators and risk factors for CDB-4124
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for CDB-4124 | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
CDB-4124 (Proellex™, Progenta™) is a selective progesterone receptor modulator.[1]
References
- ↑ Attardi BJ, Burgenson J, Hild SA, Reel JR (2004). "In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone". J Steroid Biochem Mol Biol 88 (3): 277-88. doi:10.1016/j.jsbmb.2003.12.004. PMID 15120421.
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
